Anti-SEMA4D Monoclonal Antibody VX15/2503
17-001570
Phase 1 mab terminated
Quick answer
Anti-SEMA4D Monoclonal Antibody VX15/2503 for Metastatic Melanoma is a Phase 1 program (mab) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VACCINEX, INC.
- Indication
- Metastatic Melanoma
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated